Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|August 22, 2022
Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US populationProwpanga Udompap, Terry M Therneau, Rachel E Canning, et al.The American Journal of Gastroenterology|June 9, 2026
Diagnostic Deserts: National Gaps in Screening and Care Infrastructure for Metabolic Dysfunction-Associated Steatotic Liver DiseaseMitchell W Clayton, Joanne T Benson, Olivia J Bobek, et al.Journal of Primary Care & Community Health|January 25, 2024
Impact of Program Changes Including Telemedicine and Telephonic Care During the COVID-19 Pandemic in Preventing 30-Day Hospital Readmission for Patients in a Care Transitions ProgramPaul Y Takahashi, Bjorg Thorsteinsdottir, Rozalina G McCoy, et al.Journal of Patient Experience|January 22, 2026
From Barriers to Solutions: A Design Synthesis to Improve Video Visit Experience for Older AdultsLindsey M Philpot, Priya Ramar, Rachel E Canning, et al.Hepatology Communications|August 7, 2026
Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholdsAlina M Allen, Olivia J Bobek, Rachel E Canning, et al.JMIR Human Factors|August 20, 2025
Patient-Derived Design Principles for Technology-Enabled Healing at Home Following Hospital Discharge: Mixed Methods StudyLindsey M Philpot, Abhinav Singla, Sagar B Dugani, et al.Journal of Hepatology|July 17, 2022
Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial designAlina M Allen, Terry M Therneau, Omar T Ahmed, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Performance of AI-Enabled Electrocardiogram in the Prediction of Metabolic Dysfunction-Associated Steatotic Liver DiseaseProwpanga Udompap, Kan Liu, Itzhak Zachi Attia, et al.Pageof 1